Clinical Research Directory
Browse clinical research sites, groups, and studies.
Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms
Sponsor: Oui Therapeutics, Inc.
Summary
This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.
Official title: Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms in a Randomized Controlled Trial (RCT)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-12-09
Completion Date
2026-07-31
Last Updated
2026-01-05
Healthy Volunteers
No
Conditions
Interventions
OTX-601 Digital Therapeutic
Prescription digital therapeutic designed to overcome existing barriers and deliver evidence-based treatment for PTSD
OTX-003 Comparator app
Comparator designed to match interface of intervention while providing no active treatment.
Locations (1)
Florida State University
Tallahassee, Florida, United States